Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6142
Reference
Drug alert 12/2017
Name
Drug alert class 2 no 12 2017: medicines recall action within 48 hours [Pfizer Ireland Pharmaceuticals - Lipitor (Atorvastatin) 80mg film-coated tablets]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Pfizer is recalling three batches as a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not released to the market. The above batches were identified as being potentially affected by the same issue during the root cause investigation, although no out of specification microbiological results have been reported for these batches.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2017-11-27 00:00:00
Click to go back to homepage